The recent capital raising took it's toll as alot of holders took out an insurance policy by exiting those parcels, preventing the rise we saw last time above $1.
As Southoz stated the FDA could still approve it, even if this meeting is negative, fingers crossed for a positive outcome.
Add to My Watchlist
What is My Watchlist?